tiprankstipranks
Lonza Group (LZAGY)
OTHER OTC:LZAGY

Lonza Group (LZAGY) Stock Price & Analysis

101 Followers

LZAGY Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$34.54 - $65.79
Previous Close$55.29
Volume48.98K
Average Volume (3M)244.47K
Market Cap
$41.02B
Enterprise Value$41.50B
Total Cash (Recent Filing)CHF2.22B
Total Debt (Recent Filing)CHF2.59B
Price to Earnings (P/E)55.9
Beta1.42
Jul 25, 2024
Dividend Yield0.52%
Share Statistics
EPS (TTM)0.99
Shares OutstandingN/A
10 Day Avg. Volume60,277
30 Day Avg. Volume244,471
Standard Deviation0.09
R-Squared0.31
Alpha0.00424
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Financials

Annual

Options Prices

Currently, No data available
---

Ownership Overview

0.00%0.06%<0.01%99.94%
0.00%
Insiders
<0.01% Other Institutional Investors
99.94% Public Companies and
Individual Investors

LZAGY FAQ

What was Lonza Group’s price range in the past 12 months?
Lonza Group lowest stock price was $34.54 and its highest was $65.79 in the past 12 months.
    What is Lonza Group’s market cap?
    Currently, no data Available
    When is Lonza Group’s upcoming earnings report date?
    Lonza Group’s upcoming earnings report date is Jul 25, 2024 which is in 91 days.
      How were Lonza Group’s earnings last quarter?
      Lonza Group released its earnings results on Jan 26, 2024. The company reported $0.727 earnings per share for the quarter, missing the consensus estimate of $0.783 by -$0.056.
        Is Lonza Group overvalued?
        According to Wall Street analysts Lonza Group’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Lonza Group pay dividends?
          Lonza Group pays a Annually dividend of $0.11 which represents an annual dividend yield of 0.52%. See more information on Lonza Group dividends here
            What is Lonza Group’s EPS estimate?
            Lonza Group’s EPS estimate is $0.56.
              How many shares outstanding does Lonza Group have?
              Lonza Group has 744,687,500 shares outstanding.
                What happened to Lonza Group’s price movement after its last earnings report?
                Lonza Group reported an EPS of $0.727 in its last earnings report, missing expectations of $0.783. Following the earnings report the stock price went up 15.002%.
                  Which hedge fund is a major shareholder of Lonza Group?
                  Among the largest hedge funds holding Lonza Group’s share is Fisher Asset Management LLC. It holds Lonza Group’s shares valued at N/A.
                    ---

                    Lonza Group Stock Smart Score

                    Company Description

                    Lonza Group

                    Lonza Group AG engages in the supply of pharmaceutical, healthcare, and life science products. It operates through the following segments: Pharma & Biotech; Specialty Ingredients; and Corporate. The Pharma & Biotech segment comprises development and manufacture of customized active pharmaceutical ingredients and biopharmaceuticals as well as formulation services and delivery systems. The Specialty Ingredients segment consists of two divisions, consumer health and consumer resources and protection. The Corporate segment includes corporate functions, such as finance and accounting, legal, communication, information technology, and human resources. The company was founded in 1897 and is headquartered in Basel, Switzerland.
                    ---

                    LZAGY Company Deck

                    ---

                    LZAGY Earnings Call

                    Q4 2024
                    0:00 / 0:00
                    ---
                    Similar Stocks
                    Company
                    Price & Change
                    Follow
                    Bristol-Myers Squibb
                    Sanofi
                    GlaxoSmithKline
                    Novartis
                    AbbVie
                    Popular Stocks
                    ---
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis